1. Home
  2. CASI vs GNS Comparison

CASI vs GNS Comparison

Compare CASI & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • GNS
  • Stock Information
  • Founded
  • CASI 1991
  • GNS 2002
  • Country
  • CASI China
  • GNS Singapore
  • Employees
  • CASI N/A
  • GNS N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • GNS Other Consumer Services
  • Sector
  • CASI Health Care
  • GNS Real Estate
  • Exchange
  • CASI Nasdaq
  • GNS Nasdaq
  • Market Cap
  • CASI 35.0M
  • GNS 36.1M
  • IPO Year
  • CASI 1996
  • GNS 2022
  • Fundamental
  • Price
  • CASI $2.21
  • GNS $0.31
  • Analyst Decision
  • CASI Strong Buy
  • GNS
  • Analyst Count
  • CASI 1
  • GNS 0
  • Target Price
  • CASI $6.00
  • GNS N/A
  • AVG Volume (30 Days)
  • CASI 8.1K
  • GNS 5.7M
  • Earning Date
  • CASI 03-27-2025
  • GNS 12-27-2024
  • Dividend Yield
  • CASI N/A
  • GNS N/A
  • EPS Growth
  • CASI N/A
  • GNS N/A
  • EPS
  • CASI N/A
  • GNS N/A
  • Revenue
  • CASI $22,055,000.00
  • GNS $16,147,348.00
  • Revenue This Year
  • CASI N/A
  • GNS N/A
  • Revenue Next Year
  • CASI $134.79
  • GNS $47.43
  • P/E Ratio
  • CASI N/A
  • GNS N/A
  • Revenue Growth
  • CASI N/A
  • GNS N/A
  • 52 Week Low
  • CASI $2.04
  • GNS $0.29
  • 52 Week High
  • CASI $7.67
  • GNS $6.97
  • Technical
  • Relative Strength Index (RSI)
  • CASI 35.91
  • GNS 34.45
  • Support Level
  • CASI $2.15
  • GNS $0.29
  • Resistance Level
  • CASI $2.49
  • GNS $0.41
  • Average True Range (ATR)
  • CASI 0.15
  • GNS 0.05
  • MACD
  • CASI 0.00
  • GNS -0.00
  • Stochastic Oscillator
  • CASI 35.42
  • GNS 13.71

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.

Share on Social Networks: